Breaking the Silence: Regulation of HIV Transcription and Latency on the Road to a Cure
Viruses · 2023
DOI: 10.3390/v15122435 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, 2023. Verfasst von Natasha N Duggan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Microbiology, Scripps Research, La Jolla, CA 92037, USA. Hauptthemen laut MEDLINE: HIV Infections, HIV Seropositivity, HIV-1. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 305 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH/NIAID).
Abstract (Originalsprache)
Antiretroviral therapy (ART) has brought the HIV/AIDS epidemic under control, but a curative strategy for viral eradication is still needed. The cessation of ART results in rapid viral rebound from latently infected CD4+ T cells, showing that control of viral replication alone does not fully restore immune function, nor does it eradicate viral reservoirs. With a better understanding of factors and mechanisms that promote viral latency, current approaches are primarily focused on the permanent silencing of latently infected cells (“block and lock”) or reactivating HIV-1 gene expression in latently infected cells, in combination with immune restoration strategies to eliminate HIV infected cells from the host (“shock and kill”). In this review, we provide a summary of the current, most promising approaches for HIV-1 cure strategies, including an analysis of both latency-promoting agents (LPA) and latency-reversing agents (LRA) that have shown promise in vitro, ex vivo, and in human clinical trials to reduce the HIV-1 reservoir.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunology and Microbiology, Scripps Research, La Jolla, CA 92037, USA.
- NCI Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
ORCID-Profile: Natasha N Duggan, Lars Pache
Förderung
- NIAID NIH HHS
- the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH/NIAID)
Zitieren
APA
Duggan, N. N., Dragic, T., Chanda, S. K., & Pache, L. (2023). Breaking the Silence: Regulation of HIV Transcription and Latency on the Road to a Cure. Viruses. https://doi.org/10.3390/v15122435
Vancouver
Duggan NN, Dragic T, Chanda SK, Pache L. Breaking the Silence: Regulation of HIV Transcription and Latency on the Road to a Cure. Viruses. 2023. doi:10.3390/v15122435
BibTeX
@article{Duggan2023,
author = {Duggan, Natasha N and Dragic, Tatjana and Chanda, Sumit K and Pache, Lars},
title = {Breaking the Silence: Regulation of HIV Transcription and Latency on the Road to a Cure},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15122435}
}
EUVIMED